Cheng-Chao Liang, MD
Far Eastern Memorial Hospital
6
6
3
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+4 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (6)
Research Network
Collaboration Network
Research Areas & Affiliations
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Chen-Hua Liu, MD
National Taiwan University Hospital
Shared therapeutic areas:
Worked with same sponsors:
Shih-Jer Hsu, MD
National Taiwan University Hospital, Yun-Lin Branch
Shared therapeutic areas:
Worked with same sponsors:
Peir-Haur Hung, MD
Chiayi Christian Hospital
Shared therapeutic areas:
Worked with same sponsors:
Ding-Shinn Chen, MD
National Taiwan University Hospital
Shared therapeutic areas:
Worked with same sponsors:
Jia-Horng Kao, MD, PhD
National Taiwan University Hospital
Shared therapeutic areas:
Worked with same sponsors:
Pei-Jer Chen, MD
National Taiwan University Hospital
Shared therapeutic areas:
Worked with same sponsors:
Jun-Herng Chen, MD
National Taiwan University Hospital, Yun-Lin Branch
Shared therapeutic areas:
Worked with same sponsors:
Hung-Bin Tsai, MD
St. Martin De Porres Hospital
Shared therapeutic areas:
Worked with same sponsors:
Jou-Wei Lin, MD
National Taiwan University Hospital, Yun-Lin Branch
Shared therapeutic areas:
Worked with same sponsors:
Ming-Yang Lai, MD
National Taiwan University Hospital
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (6)
Showing 6 of 6 trials
Randomized Trial of 24 or 48 Weeks of Peginterferon Alfa-2a Plus Ribavirin for HCV Genotype 1-infected Patients
Peginterferon Alfa-2a and Ribavirin for Genotype 2 Chronic Hepatitis C: Duration and Ribavirin Dose Stratified by RVR
Safety Profiles of Liver Biopsy in Hemodialysis Patients With Chronic Viral Hepatitis Pre-treated With Vasopressin
Pegylated Interferon Alfa-2a for Dialysis Patients With Acute Hepatitis C
Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Negative Chronic Hepatitis B
Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Positive Chronic Hepatitis B
All 6 trials loaded